Search

Your search keyword '"Schlemmer, H."' showing total 753 results
Start Over Author "Schlemmer, H."
753 results on '"Schlemmer, H."'

2. Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial

Author

Fink, C.A., Ristau, J., Buchele, C., Klüter, S., Liermann, J., Hoegen-Saßmannshausen, P., Sandrini, E., Lentz-Hommertgen, A., Baumann, L., Andratschke, N., Baumgartl, M., Li, M., Reiner, M., Corradini, S., Hörner-Rieber, J., Bonekamp, D., Schlemmer, H.-P., Belka, C., Guckenberger, M., Debus, J., and Koerber, S.A.

Published
2024
Full Text
View/download PDF

5. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

Author

Hoegen, P., Zhang, K. S., Tonndorf-Martini, E., Weykamp, F., Regnery, S., Naumann, P., Lang, K., Ristau, J., Körber, S. A., Dreher, C., Buchele, C., Rippke, C., Renkamp, C. K., Paul, K. M., König, L., Büsch, C., Krisam, J., Sedlaczek, O., Schlemmer, H.-P., Niyazi, M., Corradini, S., Debus, J., Klüter, S., and Hörner-Rieber, J.

Published
2022
Full Text
View/download PDF

12. Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial

Author

Fink, C A, Ristau, J, Buchele, C, Klüter, S, Liermann, J, Hoegen-Saßmannshausen, P, Sandrini, E, Lentz-Hommertgen, A, Baumann, L, Andratschke, N, Baumgartl, M, Li, M, Reiner, M, Corradini, S, Hörner-Rieber, J, Bonekamp, D, Schlemmer, H-P, Belka, C, Guckenberger, M, Debus, J, Koerber, S A, Fink, C A, Ristau, J, Buchele, C, Klüter, S, Liermann, J, Hoegen-Saßmannshausen, P, Sandrini, E, Lentz-Hommertgen, A, Baumann, L, Andratschke, N, Baumgartl, M, Li, M, Reiner, M, Corradini, S, Hörner-Rieber, J, Bonekamp, D, Schlemmer, H-P, Belka, C, Guckenberger, M, Debus, J, and Koerber, S A

Abstract

BACKGROUND Due to superior image quality and daily adaptive planning, MR-guided stereotactic body radiation therapy (MRgSBRT) has the potential to further widen the therapeutic window in radiotherapy of localized prostate cancer. This study reports on acute toxicity rates and patient-reported outcomes after MR-guided adaptive ultrahypofractionated radiotherapy for localized prostate cancer within the prospective, multicenter phase II SMILE trial. MATERIALS AND METHODS A total of 69 patients with localized prostate cancer underwent MRgSBRT with daily online plan adaptation. Inclusion criteria comprised a tumor stage ≤ T3a, serum PSA value ≤ 20 ng/ml, ISUP Grade group ≤ 4. A dose of 37.5 Gy was prescribed to the PTV in five fractions on alternating days with an optional simultaneous boost of 40 Gy to the dominant intraprostatic lesion defined by multiparametric MRI. Acute genitourinary (GU-) and gastrointestinal (GI-) toxicity, as defined by CTCAE v. 5.0 and RTOG as well as patient-reported outcomes according to EORTC QLQ-C30 and -PR25 scores were analyzed at completion of radiotherapy, 6 and 12 weeks after radiotherapy and compared to baseline symptoms. RESULTS There were no toxicity-related treatment discontinuations. At the 12-week follow-up visit, no grade 3 + toxicities were reported according to CTCAE. Up until the 12-week visit, in total 16 patients (23 %) experienced a grade 2 GU or GI toxicity. Toxicity rates peaked at the end of radiation therapy and subsided within the 12-week follow-up period. At the 12-week follow-up visit, no residual grade 2 GU toxicities were reported and 1 patient (1 %) had residual grade 2 enteritic symptoms. With exception to a significant improvement in the emotional functioning score following MRgSBRT, no clinically meaningful changes in the global health status nor in relevant subscores were reported. CONCLUSION Daily online-adaptive MRgSBRT for localized prostate cancer resulted in an excellent overall toxicity profile without a

Published
2024

13. Mikrovaskuläre Veränderungen bei COVID-19

Author

Wagner, W. L., Hellbach, K., Fiedler, M. O., Salg, G. A., Wehrse, E., Ziener, C. H., Merle, U., Eckert, C., Weber, T. F., Stiller, W., Wielpütz, M. O., Dullin, C., Kenngott, H. G., Schlemmer, H.-P., Weigand, M. A., Schirmacher, P., Longerich, T., Kauczor, H.-U., Kommoss, F. K.-F., and Schwab, C.

Published
2020
Full Text
View/download PDF

14. Treatment of Small Renal Masses

Author

Schostak, M., Wendler, J. J., Baumunk, D., Blana, A., Ganzer, R., Franiel, T., Hadaschik, B., Henkel, T., Köhrmann, K. U., Köllermann, J., Kuru, T., Machtens, S., Roosen, A., Salomon, G., Schlemmer, H. P., Sentker, L., Witzsch, U., Liehr, U. B., Kramer, Mario W., Section editor, Merseburger, Axel S., Section editor, Merseburger, Axel S., editor, and Burger, Maximilian, editor

Published
2019
Full Text
View/download PDF

22. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma

Author

Dieter, S.M., Heining, C., Agaimy, A., Huebschmann, D., Bonekamp, D., Hutter, B., Ehrenberg, K.R., Fröhlich, M., Schlesner, M., Scholl, C., Schlemmer, H.-P., Wolf, S., Mavratzas, A., Jung, C.S., Gröschel, S., von Kalle, C., Eils, R., Brors, B., Penzel, R., Kriegsmann, M., Reuss, D.E., Schirmacher, P., Stenzinger, A., Federspil, P.A., Weichert, W., Glimm, H., and Fröhling, S.

Published
2017
Full Text
View/download PDF

25. Attitudes and perceptions of radiologists towards online (virtual) oncologic multidisciplinary team meetings during the COVID-19 pandemic—a survey of the European Society of Oncologic Imaging (ESOI)

Author

Bonanno, N. Cioni, D. Caruso, D. Cyran, C.C. Dinkel, J. Fournier, L. Gourtsoyianni, S. Hoffmann, R.-T. Laghi, A. Martincich, L. Mayerhoefer, M.E. Zamboni, G.A. Sala, E. Schlemmer, H.-P. Neri, E. D’Anastasi, M. and Bonanno, N. Cioni, D. Caruso, D. Cyran, C.C. Dinkel, J. Fournier, L. Gourtsoyianni, S. Hoffmann, R.-T. Laghi, A. Martincich, L. Mayerhoefer, M.E. Zamboni, G.A. Sala, E. Schlemmer, H.-P. Neri, E. D’Anastasi, M.

Abstract

Objectives: To explore radiologists’ opinions regarding the shift from in-person oncologic multidisciplinary team meetings (MDTMs) to online MDTMs. To assess the perceived impact of online MDTMs, and to evaluate clinical and technical aspects of online meetings. Methods: An online questionnaire including 24 questions was e-mailed to all European Society of Oncologic Imaging (ESOI) members. Questions targeted the structure and efficacy of online MDTMs, including benefits and limitations. Results: A total of 204 radiologists responded to the survey. Responses were evaluated using descriptive statistical analysis. The majority (157/204; 77%) reported a shift to online MDTMs at the start of the pandemic. For the most part, this transition had a positive effect on maintaining and improving attendance. The majority of participants reported that online MDTMs provide the same clinical standard as in-person meetings, and that interdisciplinary discussion and review of imaging data were not hindered. Seventy three of 204 (35.8%) participants favour reverting to in-person MDTs, once safe to do so, while 7/204 (3.4%) prefer a continuation of online MDTMs. The majority (124/204, 60.8%) prefer a combination of physical and online MDTMs. Conclusions: Online MDTMs are a viable alternative to in-person meetings enabling continued timely high-quality provision of care with maintained coordination between specialties. They were accepted by the majority of surveyed radiologists who also favoured their continuation after the pandemic, preferably in combination with in-person meetings. An awareness of communication issues particular to online meetings is important. Training, improved software, and availability of support are essential to overcome technical and IT difficulties reported by participants. Key Points: • Majority of surveyed radiologists reported shift from in-person to online oncologic MDT meetings during the COVID-19 pandemic. • The shift to online MDTMs was feasible and gen

Published
2023

27. In vivo Reproduzierbarkeit von Radiomics-Merkmalen zwischen verschiedenen MRT-Geräten bei Patienten mit monoklonalen Plasmazellerkrankungen – eine prospektive Bi-institutionelle Studie.

Author

Wennmann, M, additional, Bauer, F, additional, Neher, P, additional, Grözinger, M, additional, Rotkopf, L, additional, Goldschmidt, H, additional, Weber, T F, additional, Delorme, S, additional, Maier-Hein, K, additional, Schlemmer, H P, additional, and Götz, M, additional

Published
2023
Full Text
View/download PDF

28. Deep learning zur automatischen Messung des Scheinbaren Diffusionskoeffizienten (ADC) aus multizentrischen retrospektiven Ganzkörper-MRT Daten bei Patienten mit Multiplem Myelom

Author

Stanczyk, N, additional, Wennmann, M, additional, Neher, P, additional, Kahl, K C, additional, Horger, M, additional, Goldschmidt, H, additional, Schlemmer, H P, additional, Weber, T F, additional, Delorme, S, additional, Kurz, F T, additional, and Maier-Hein, K, additional

Published
2023
Full Text
View/download PDF

30. Deep Learning und Radiomics zur automatischen, objektiven, umfassenden Knochenmarkscharakterisierung aus Ganzkörper-MRTs – eine multizentrische Machbarkeitsstudie

Author

Wennmann, M, additional, Klein, A, additional, Bauer, F, additional, Chmelik, J, additional, Uhlenbrock, C, additional, Grözinger, M, additional, Weber, T F, additional, Goldschmidt, H, additional, Delorme, S, additional, Maier-Hein, K, additional, and Schlemmer, H P, additional

Published
2023
Full Text
View/download PDF

32. Fokale Therapie des Prostatakarzinoms

Author

Ganzer, R., Franiel, T., Köllermann, J., Kuru, T., Baumunk, D., Blana, A., Hadaschik, B., von Hardenberg, J., Henkel, T., Köhrmann, K.-U., Liehr, U.-B., Machtens, S., Roosen, A., Salomon, G., Schlemmer, H.-P., Sentker, L., Wendler, J., Witzsch, U., and Schostak, M.

Published
2017
Full Text
View/download PDF

34. HELMHOLTZ CROSS-CUTTING ACTIVITY RADIATION RESEARCH : White Paper

Author

Becker, F., Bohnstedt, A., Gutberlet, T., Graeff, C., Hellweg, C. E., Heuel-Fabianek, B., Jäkel, O., Kaluza, M. C., Karger, C., Kausch, C., Kiele, S., Kopka, K., Brückel, T., Kourkafas, G., Krause, M., Kriehuber, R., Kurth, I., Neumaier, B., Pütz, T., Raff, J., Richter, C., Rühm, W., Sachs, S., Combs, S., Sauerborn, M., Schmid, T., Schramm, U., Seco, J., Schlemmer, H.-P., Staudt, C., Stephan, F., Stumpf, T., Troost, E., Wagner, A., Cordes, N., Denker, A., Durante, M., Fahmy, K., Förster, S., and Fournier, C.

Abstract

Darmstadt : GSI Helmholtzzentrum für Schwerionenforschung 99 p. (2023)., Published by GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt

Published
2023
Full Text
View/download PDF

36. Treatment of Small Renal Masses

Author

Schostak, M., primary, Wendler, J. J., additional, Baumunk, D., additional, Blana, A., additional, Ganzer, R., additional, Franiel, T., additional, Hadaschik, B., additional, Henkel, T., additional, Köhrmann, K. U., additional, Köllermann, J., additional, Kuru, T., additional, Machtens, S., additional, Roosen, A., additional, Salomon, G., additional, Schlemmer, H. P., additional, Sentker, L., additional, Witzsch, U., additional, and Liehr, U. B., additional

Published
2018
Full Text
View/download PDF

37. MRT/TRUS-fusionierte Biopsiesysteme: Stellenwert bei der fokalen Therapie des Prostatakarzinoms

Author

Franz, T., von Hardenberg, J., Blana, A., Cash, H., Baumunk, D., Salomon, G., Hadaschik, B., Henkel, T., Herrmann, J., Kahmann, F., Köhrmann, K.-U., Köllermann, J., Kruck, S., Liehr, U.-B., Machtens, S., Peters, I., Radtke, J. P., Roosen, A., Schlemmer, H.-P., Sentker, L., Wendler, J. J., Witzsch, U., Stolzenburg, J.‑U., Schostak, M., and Ganzer, R.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results